komet-008: a phase i trial of ziftomenib combinations in kmt2a-rearranged or npm1-mutant aml
Published 6 months ago • 130 plays • Length 2:51Download video MP4
Download video MP3
Similar videos
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
3:46
update on komet-001: identifying the optimal dose of ziftomenib for patients with r/r aml
-
3:55
ziftomenib: a menin inhibitor for r/r npm1-mutated aml
-
1:17
ctr insertion by dr. jeffrey whitman
-
1:06
in the lab: weighing samples 8 - freezing
-
12:18
rt clinic: oxygen tank duration - intelliox demo
-
2:01
the future of menin inhibitors in aml
-
![[online seminar] new holladay report for best results in iol calculations & refractive surgery](https://i.ytimg.com/vi/6lV2600PL14/mqdefault.jpg)
1:03:27
[online seminar] new holladay report for best results in iol calculations & refractive surgery
-
4:10
thermo scientific pikoreal real-time pcr system
-
2:43
gemtuzumab ozogamicin in frontline aml therapy
-
3:45
tetrahedron : video assignment chm 4323
-
1:14
highlights in quality management from ebmt
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:19
avidity sequencing™ technology video
-
29:50
tanja e. mehlstäubler "next-generation multi-ion optical clocks"
-
1:43
highlights from ebmt 2022
-
0:18
time-lapse imaging of ht-1080 cells by pasqualini lab | holomonitor®
-
5:20
actome pitch - biofit 2022
-
6:10
element aviti™ system - instrument demonstration
-
0:23
aqualog eem capture realtime analysis of quinine sulfate standard solution